Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention.
AffiliationGenesis Prevention Centre and Nightingale Breast Screening Centre, University Hospital of South Manchester, UK.
MetadataShow full item record
AbstractThe aim of this study is to determine breast cancer risk at mammographic screening episodes and integrate standard risk factors with mammographic density and genetic data to assess changing the screening interval based on risk and offer women at high risk preventive strategies. We report our experience of assessing breast cancer risk within the U.K. National Health Service Breast Screening Program using results from the first 10,000 women entered into the "Predicting Risk Of breast Cancer At Screening" study. Of the first 28,849 women attending for screening at fifteen sites in Manchester 10,000 (35%) consented to study entry and completed the questionnaire. The median 10-year Tyrer-Cuzick breast cancer risk was 2.65% (interquartile range, 2.10-3.45). A total of 107 women (1.07%) had 10-year risks 8% or higher (high breast cancer risk), with a further 8.20% having moderately increased risk (5%-8%). Mammographic density (percent dense area) was 60% or more in 8.3% of women. We collected saliva samples from 478 women for genetic analysis and will extend this to 18% of participants. At time of consent to the study, 95.0% of women indicated they wished to know their risk. Women with a 10-year risk of 8% or more or 5% to 8% and mammographic density of 60% or higher were invited to attend or be telephoned to receive risk counseling; 81.9% of those wishing to know their risk have received risk counseling and 85.7% of these were found to be eligible for a risk-reducing intervention. These results confirm the feasibility of determining breast cancer risk and acting on the information in the context of population-based mammographic screening.
CitationAssessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention. 2012, 5 (7):943-51 Cancer Prev Res
JournalCancer Prevention Research
- Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention.
- Authors: Evans DG, Brentnall AR, Harvie M, Dawe S, Sergeant JC, Stavrinos P, Astley S, Wilson M, Ainsworth J, Cuzick J, Buchan I, Donnelly LS, Howell A
- Issue date: 2014 Oct
- Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
- Authors: Brentnall AR, Cuzick J, Buist DSM, Bowles EJA
- Issue date: 2018 Sep 1
- Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
- Authors: van Veen EM, Brentnall AR, Byers H, Harkness EF, Astley SM, Sampson S, Howell A, Newman WG, Cuzick J, Evans DGR
- Issue date: 2018 Apr 1
- [Tailored Breast Screening Trial (TBST)].
- Authors: Paci E, Mantellini P, Giorgi Rossi P, Falini P, Puliti D, TBST Working Group.
- Issue date: 2013 Jul-Oct
- Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial.
- Authors: Loehberg CR, Jud SM, Haeberle L, Heusinger K, Dilbat G, Hein A, Rauh C, Dall P, Rix N, Heinrich S, Buchholz S, Lex B, Reichler B, Adamietz B, Schulz-Wendtland R, Beckmann MW, Fasching PA
- Issue date: 2010 May